CADILA HEALTHCARE Surges by 10%; BSE HEALTHCARE Index Up 4.5%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  •
  • MyStocks
MEMBER'S LOGIN

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Markets will remain closed on 2nd April, 2020 on account of Ram Navami.

CADILA HEALTHCARE Surges by 10%; BSE HEALTHCARE Index Up 4.5%
Fri, 20 Mar 09:32 AM

CADILA HEALTHCARE share price has zoomed 10% and is presently trading at Rs 274.

Meanwhile, the BSE HEALTHCARE Index is at 11,925 (up 4.5%).

Among the top Gainers in the BSE HEALTHCARE Index today are CADILA HEALTHCARE (up 10.5%) and IPCA LABS (up 18.6%).

ERIS LIFESCIENCES LIMITED (down 1.5%) and SHILPA MEDICARE (down 5.0%) are among the top losers today.

Over the last one year, CADILA HEALTHCARE has moved down from Rs 337 to Rs 274, registering a loss of Rs 64 (down 19.5%).

On the other hand, the BSE HEALTHCARE has moved down from 14,270 to 11,925, loss of 2,345 points (down 16.5%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 86.7%), J.B.CHEMICALS (up 62.6%) and IPCA LABS (up 62.4%).

Now or Never: Access Details of the No. 1 Small Cap Stock of 2020

What About the Benchmark Indices?

The BSE Sensex is at 28,861 (up 1.7%).

The top gainers among the BSE Sensex stocks today are ONGC (up 5.5%), POWER GRID (up 5.5%) and BAJAJ AUTO (up 5.1%). Other gainers include HUL (up 5.1%) and ITC (up 5.0%). The most traded stocks in the BSE Sensex are SBI and ICICI BANK.

In the meantime, NSE Nifty is at 8,441 (up 0.3%). The top gainers in the NSE Nifty include GAIL (up 6.4%), POWER GRID (up 5.7%) and ONGC (up 4.8%). Other gainers include ITC (up 4.3%) and SUN PHARMA (up 4.2%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved down from 38,363 to 28,861, registering a loss of 9,502 points (down 25.04%).

CADILA HEALTHCARE Financial Update...

CADILA HEALTHCARE net profit down at Rs 4 billion for the quarter ended December 2019, compared to a loss of Rs 5 billion a year ago. Net Sales rose 1.7% to Rs 36.4 billion during the period as against Rs 35.8 billion in October-December 2018.

For the year ended March 2019, CADILA HEALTHCARE reported 4.8% increase in net profit to Rs 18.5 billion compared to net profit of Rs 17.7 billion during FY18.

Revenue of the company grew 10.1% to Rs 132 billion during FY19.

The current Price to earnings ratio of CADILA HEALTHCARE, based on rolling 12 month earnings, stands at 22.4x.

Archives

RSS RSS



What else is happening in the markets today? Dig in...

Advertisement
Stock Crash 2020 Creates a Potential 10x Opportunity
In less than 48 hours from now, the opportunity to access details of what we believe is The No. 1 Small Cap Stock of 2020 will disappear. This stock could be a potential 10x opportunity. And that's why I strongly recommend you don't miss it. Access full details here...

Equitymaster requests your view! Post a comment on "CADILA HEALTHCARE Surges by 10%; BSE HEALTHCARE Index Up 4.5%". Click here!

  

Stock Market Updates

Sensex Crashes 1,203 Points; IT and Banking Stocks Witness Selling (Today's Market)

Apr 1, 2020 Closing

Indian share markets extended losses in the first trading session of FY21, as the number of coronavirus cases in the country continued to rise.

PRESTIGE ESTATES Surges by 6%; BSE REALTY Index Down 3.0% (Today's Market)

Apr 1, 2020 03:33 PM

PRESTIGE ESTATES share price has surged by 6% and its current market price is Rs 185. The BSE REALTY is down by 3.0%. The top gainers in the BSE REALTY Index are PRESTIGE ESTATES (up 6.5%) and SOBHA LIMITED (up 5.6%). The top losers are OMAXE LTD (down 0.5%) and GODREJ PROPERTIES (down 1.0%).

NESCO Plunges by 5%; BSE CAPITAL GOODS Index Down 2.6% (Today's Market)

Apr 1, 2020 03:33 PM

NESCO share price has plunged by 5% and its current market price is Rs 491. The BSE CAPITAL GOODS is down by 2.6%. The top gainers in the BSE CAPITAL GOODS Index are FINOLEX CABLES (up 7.2%) and GRAPHITE INDIA (up 5.0%). The top losers are NESCO (down 5.4%) and BHARAT ELECTRONICS (down 6.6%).

CAPRI GLOBAL CAPITAL Plunges by 8%; BSE 500 Index Down 3.3% (Today's Market)

Apr 1, 2020 03:33 PM

CAPRI GLOBAL CAPITAL share price has plunged by 8% and its current market price is Rs 172. The BSE 500 is down by 3.3%. The top gainers in the BSE 500 Index are JINDAL SAW LTD (up 8.3%) and GUJ. STATE PETRONET (up 7.5%). The top losers are CAPRI GLOBAL CAPITAL (down 8.5%) and MRF LTD. (down 5.2%).

HCL TECHNOLOGIES Plunges by 5%; BSE IT Index Down 5.6% (Today's Market)

Apr 1, 2020 03:33 PM

HCL TECHNOLOGIES share price has plunged by 5% and its current market price is Rs 440. The BSE IT is down by 5.6%. The top gainers in the BSE IT Index are NIIT TECHNOLOGIES (up 2.9%) and FIRSTSOURCE SOL. (up 2.5%). The top losers are HCL TECHNOLOGIES (down 5.2%) and ORACLE FINANCIAL (down 5.2%).

MAHINDRA HOLIDAYS Plunges by 6%; BSE 500 Index Down 3.3% (Today's Market)

Apr 1, 2020 03:31 PM

MAHINDRA HOLIDAYS share price has plunged by 6% and its current market price is Rs 141. The BSE 500 is down by 3.3%. The top gainers in the BSE 500 Index are PRESTIGE ESTATES (up 8.0%) and JUBILANT LIFE SCIENCES (up 7.9%). The top losers are MAHINDRA HOLIDAYS (down 6.5%) and MRF LTD. (down 5.2%).

View More Indian Share Market News

Most Popular

If I Were to Recommend One Stock Amid Coronavirus Outbreak, This Would be It.(Profit Hunter)

Mar 19, 2020

Coronavirus outbreak has made no impact on the long term prospects of my favourite smallcap. What it has indeed done is brought the company below my buy price, making it even more attractive investment at current price.

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020(The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

Why India Will Be the Biggest Winner in a Post-Coronavirus World(The 5 Minute Wrapup)

Mar 19, 2020

The way businesses operate will change in a major way post the coronavirus impact. Here's why India stands to benefit from this change...

A Big Trading Opportunity is Coming Your Way Soon(Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

How to Trade the Coronavirus Crash - Download this FREE Report Now
How to Profit Even During These Times of Crisis: Vijay Bhambwani Reveals his Strategy...
The Best Stocks For 2020 - How to Spot Multibagger Ideas. FREE Sign up!
Free Report: The Secret to Increasing Your Trading Profits Daily!
Find Out Our Top 7 Bluechips for 2020 Virtually FREE. Click Here Now!

S&P BSE SENSEX


Apr 1, 2020 (Close)

OTHER USEFUL LINKS

MARKET STATS


ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
  • Get Equitymaster Android App on Google Play
  • Get Equitymaster iOS App on App Store
FOLLOW

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.